TELO Earnings

Quarterly EPS
$-0.20
Q3 2024
$-0.10
Q4 2024
$-0.07
Q1 2025
$-0.17
Q2 2025
$-0.03
Q3 2025
$-0.06
Q4 2025
$-0.03
Q1 2026
$-0.79
Q2 2026
Latest RevenueN/A
Latest Net Income-1721528
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.790-1721528-364.7%
Q1 2026-$0.030-990947+57.1%
Q4 2025-$0.060-2061193+40.0%
Q3 2025-$0.030-1102294+85.0%
Q2 2025-$0.170-5069890-240.0%
Q1 2025-$0.070-2179828+69.6%
Q4 2024-$0.100-2898373
Q3 2024-$0.200-5990733
Q2 2024-$0.050-1449003
Q1 2024-$0.230-6254607
Telomir Pharmaceuticals (TELO) — Earnings